Analysts Anticipate Surgery Partners Inc (SGRY) to Announce -$0.20 EPS

Wall Street brokerages expect Surgery Partners Inc (NASDAQ:SGRY) to post earnings of ($0.20) per share for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Surgery Partners’ earnings. The highest EPS estimate is ($0.08) and the lowest is ($0.31). Surgery Partners reported earnings per share of ($0.01) during the same quarter last year, which would indicate a negative year over year growth rate of 1,900%. The firm is scheduled to report its next earnings report on Tuesday, August 14th.

On average, analysts expect that Surgery Partners will report full-year earnings of ($0.24) per share for the current fiscal year, with EPS estimates ranging from ($0.37) to ($0.11). For the next financial year, analysts forecast that the business will report earnings of $0.27 per share, with EPS estimates ranging from $0.21 to $0.33. Zacks’ EPS calculations are an average based on a survey of analysts that cover Surgery Partners.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings data on Wednesday, May 9th. The company reported ($0.26) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.05). Surgery Partners had a negative net margin of 5.13% and a negative return on equity of 1.90%. The company had revenue of $417.37 million for the quarter, compared to the consensus estimate of $410.79 million. During the same quarter in the previous year, the firm posted ($0.06) earnings per share. The business’s revenue for the quarter was up 45.8% compared to the same quarter last year.

SGRY has been the topic of a number of research analyst reports. ValuEngine lowered Surgery Partners from a “hold” rating to a “sell” rating in a research note on Tuesday, May 22nd. BidaskClub upgraded Surgery Partners from a “hold” rating to a “buy” rating in a research note on Friday, May 4th. Zacks Investment Research upgraded Surgery Partners from a “sell” rating to a “hold” rating in a research note on Thursday, April 12th. Finally, Jefferies Financial Group set a $18.00 target price on Surgery Partners and gave the stock a “buy” rating in a research note on Thursday, March 1st. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $18.29.

Shares of NASDAQ SGRY opened at $16.65 on Wednesday. The stock has a market capitalization of $807.06 million, a price-to-earnings ratio of -19.82 and a beta of 1.83. The company has a debt-to-equity ratio of 1.63, a quick ratio of 1.55 and a current ratio of 1.72. Surgery Partners has a twelve month low of $7.10 and a twelve month high of $24.05.

Institutional investors have recently made changes to their positions in the company. MetLife Investment Advisors LLC bought a new position in shares of Surgery Partners during the 1st quarter valued at about $164,000. We Are One Seven LLC bought a new position in shares of Surgery Partners during the 4th quarter valued at about $138,000. GSA Capital Partners LLP bought a new position in shares of Surgery Partners during the 1st quarter valued at about $222,000. BlueCrest Capital Management Ltd bought a new position in shares of Surgery Partners during the 4th quarter valued at about $157,000. Finally, Aperio Group LLC bought a new position in shares of Surgery Partners during the 4th quarter valued at about $173,000. Hedge funds and other institutional investors own 97.59% of the company’s stock.

Surgery Partners Company Profile

Surgery Partners, Inc, through its subsidiaries, operates surgical facilities in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

Get a free copy of the Zacks research report on Surgery Partners (SGRY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply